By Amina Niasse NEW YORK (Reuters) -Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Bone and muscle health is key to prevent the risk of falling and fractures which can lead to premature death or else have a ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.